VENTAVIS for Pulmonary hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 63 adverse event reports in the FDA FAERS database where VENTAVIS was used for Pulmonary hypertension.
Most Reported Side Effects for VENTAVIS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 63 | 17.0% | 26 | 47 |
| Death | 62 | 16.7% | 62 | 25 |
| Pulmonary arterial hypertension | 40 | 10.8% | 27 | 27 |
| Fatigue | 26 | 7.0% | 9 | 18 |
| Malaise | 26 | 7.0% | 10 | 17 |
| Pneumonia | 26 | 7.0% | 8 | 25 |
| Drug dose omission | 21 | 5.7% | 7 | 21 |
| Headache | 21 | 5.7% | 4 | 12 |
| Fluid retention | 19 | 5.1% | 9 | 17 |
| Pulmonary hypertension | 18 | 4.9% | 15 | 12 |
| Asthenia | 17 | 4.6% | 6 | 12 |
| Cough | 17 | 4.6% | 4 | 9 |
| Fall | 17 | 4.6% | 3 | 15 |
| General physical health deterioration | 17 | 4.6% | 12 | 11 |
| Oedema peripheral | 17 | 4.6% | 5 | 14 |
Other Indications for VENTAVIS
Pulmonary arterial hypertension (238)
Product used for unknown indication (31)
Cor pulmonale chronic (25)
Other Drugs Used for Pulmonary hypertension
AMBRISENTAN (18,885)
TREPROSTINIL (10,034)
MACITENTAN (5,228)
RIOCIGUAT (3,837)
SILDENAFIL (3,761)
SELEXIPAG (2,500)
EPOPROSTENOL (2,486)
TADALAFIL (2,430)
BOSENTAN (2,337)
ILOPROST (1,123)